The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safeyt Profile of Test Product Compared to Reference Product Will be Assessed.

NCT05329844 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Vildagliptin 50 MG

Sponsor

AET Laboratories Private Limited